United States Biotechnology & Medical Research

Ensysce Biosciences Inc (ENSC)

Track

Ticker: ENSC Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
GOWER BOB G Non-Executive Director
Transaction date
Purchase
Price
120.09
Quantity 22,970 -37.1%
Value US$2,601,361
GOWER BOB G Non-Executive Director
Transaction date
Purchase
Price
451.86
Quantity 81,742 +30.7%
Value US$500,305
GOWER BOB G Non-Executive Director
Transaction date
Purchase
Price
221.68
Quantity 66,885 +34.9%
Value US$1,923,261
GOWER BOB G Non-Executive Director
Transaction date
Purchase
Price
1.40
Quantity 357,143 +90.2%
Value US$500,000
Kirkpatrick Lynn Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.53
Quantity 27,000 +7.6%
Value US$14,216
Kirkpatrick Lynn Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.49
Quantity 70,000 +24.6%
Value US$34,083
0.7
MORGAN STANLEY Large shareholder
Transaction date
Sale
Price
0.00
Quantity 776,290
Value US$0
HG Vora Capital Management, LLC Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 1,000,000 +35.2%
Value US$10,000,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-03-06 2023-03-02 B Purchase
GOWER BOB G
Non-Executive Director
22,970 -37.1%
120.09
US$2,601,361 		22,970 -37.1% 120.09 US$2,601,361
2023-03-02 2023-03-01 B Purchase
GOWER BOB G
Non-Executive Director
81,742 +30.7%
451.86
US$500,305 		81,742 +30.7% 451.86 US$500,305
2023-03-02 2023-02-28 B Purchase
GOWER BOB G
Non-Executive Director
66,885 +34.9%
221.68
US$1,923,261 		66,885 +34.9% 221.68 US$1,923,261
2023-02-01 2022-12-09 B Purchase
GOWER BOB G
Non-Executive Director
357,143 +90.2%
1.40
US$500,000 		357,143 +90.2% 1.40 US$500,000
2022-05-27 2022-05-26 B Purchase
Kirkpatrick Lynn

Chief Executive Officer

Executive Director
27,000 +7.6%
0.53
US$14,216 		27,000 +7.6% 0.53 US$14,216
2022-05-27 2022-05-25 B Purchase
Kirkpatrick Lynn

Chief Executive Officer

Executive Director
70,000 +24.6%
0.49
US$34,083 		70,000 +24.6% 0.49 US$34,083
2020-06-23 2020-06-19 S Sale
0.7
MORGAN STANLEY
Large shareholder
776,290
0.00
US$0 		776,290 0.00 US$0
2018-01-17 2017-12-01 B Purchase HG Vora Capital Management, LLC Large shareholder
1,000,000 +35.2%
10.00
US$10,000,000 		1,000,000 +35.2% 10.00 US$10,000,000
Explore more

More insider trading research around Ensysce Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America